Niranjan Kanesa-thasan, Chief Medical Officer at Icosavax, Inc. (ICVX), sold 212,746 shares at $15.70 ($3.3M) on 2023-01-04, disclosed to the SEC on 2024-01-05.
Open-market sale of $3.3M ICVX by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $15.70 | 106,373 | $1.7M | 50.0% |
| 2 | $15.70 | 106,373 | $1.7M | 50.0% |
| Total | $15.70 avg | 212,746 | $3.3M | 100% |
| Filing → |
| ICVX | SELL | 2023-02-15 | $19K | — | Filing → |
| ICVX | SELL | 2022-08-02 | $22K | — | Filing → |
| ICVX | BUY | 2021-08-02 | $100K | — | Filing → |